Jul 14, 2026 06:01AM
Dec 9, 2025 08:52AM
Nov 7, 2025 07:00AM
Oct 11, 2025 04:02AM
Oct 10, 2025 06:03AM
Oct 9, 2025 04:31PM
Oct 9, 2025 12:12PM Canaccord Genuity Downgrades Akero Therapeutics (AKRO) to Hold
Oct 9, 2025 12:12PM
Oct 9, 2025 06:02AM
Oct 7, 2025 07:00AM
Sep 4, 2025 06:13AM
Aug 8, 2025 09:38AM
Aug 6, 2025 10:07AM
Aug 4, 2025 05:30AM TD Cowen Starts Akero Therapeutics (AKRO) at Buy
Jun 13, 2025 11:43AM
May 20, 2025 01:10PM
May 13, 2025 02:26PM
May 13, 2025 06:25AM
May 13, 2025 04:52AM
May 12, 2025 02:38PM
May 9, 2025 07:15AM Akero Therapeutics (AKRO) Announces Publication of Phase 2b SYMMETRY Trial in the New England Journal of Medicine
May 9, 2025 06:41AM
Apr 30, 2025 12:41AM
Apr 2, 2025 07:04AM
Mar 3, 2025 06:15AM
Jan 29, 2025 04:08PM
Jan 28, 2025 06:35AM
Jan 28, 2025 05:02AM Akero Therapeutics (AKRO) PT Raised to $80 at Citi
Jan 27, 2025 04:01PM
Jan 27, 2025 02:38PM
Jan 27, 2025 11:47AM
Jan 27, 2025 10:36AM
Jan 27, 2025 10:30AM
Jan 27, 2025 06:32AM
Jan 24, 2025 04:08PM Akero Therapeutics (AKRO) to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
Jan 17, 2025 06:39AM
Jan 16, 2025 02:56PM
Jan 9, 2025 05:18PM
Dec 30, 2024 05:30PM
Dec 30, 2024 08:49AM
Dec 19, 2024 02:00PM
Nov 18, 2024 04:12AM Citi Starts Akero Therapeutics (AKRO) at Buy
Nov 15, 2024 11:01AM
Oct 20, 2024 10:00AM
Sep 17, 2024 06:50AM
Aug 9, 2024 08:29AM
Jun 12, 2024 07:44AM
Jun 11, 2024 05:02AM

419,329 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All